Third Time's the Charm: Repair of Complex Thoracic Aneurysm in a Patient with Relapsing Polychondritis  by Hunt, Peter J.B. et al.
kidney injury after pharmacomechanical thrombolysis has been reported,
however the true incidence is unknown.
Case reports: An 18-year-old male athlete with Paget von Schroetter
disease underwent PMT using the AngioJet device and thrombolysis with
tissue plasminogen activator. Total PMT volume was 200 mL. Postopera-
tively, the patient developed hematuria, and elevated serum creatinine.
Urine output was normal, and his creatinine slowly normalized without
intervention. He successfully underwent first rib resection. A 42 year-old
male with factor V Leiden and protein C and S deficiency, but normal
preoperative serum creatinine, developed recurrent bilateral ileofemoral
deep venous thromboses. He underwent “power pulse thrombolysis” using
the AngioJet device, and subsequent catheter directed thrombolysis. Total
PMT volume was 300 mL with additional infusion of tissue plasminogen
activator. Intraoperative hematuria was noted, and postoperatively, the
patient developed an acute increase in serum creatinine. Urine output was
normal, and investigations regarding the etiology of the acute kidney injury
were inconclusive. There were no laboratory signs of hemolysis, interstitial
nephritis, or hemodynamically mediated kidney injury.
Conclusions: These two cases illustrate acute kidney injury after PMT
and thrombolysis for venous thrombosis. PMT can lead to hemolysis in cases
of high-volume injection and aspiration. In both patients, hematuria was
present during or immediately after pharmacomechanical thrombolysis.
Limiting PMT volume appears to ameliorate the risk of hemolysis, but in the
patients presented, PMT using the AngioJet device was performed with
500 mL. As the use of endovascular techniques for thrombosis increases,
further studies are needed to assess the relationship of PMT, postoperative
hemolysis, and its impact on renal function. Vigilance of PMT volume and
renal status in these patients appears warranted.
Endovascular Abdominal Aortic Aneurysm Repair in Patients With
Ventricular Assist Devices
Jean E. Starr, MD, Chittoor Sai-Sudhakar, MD, and Hamdy Elsayed-Awad,
MD. Department of Surgery and Department of Anesthesia, The Ohio
State University, Columbus, Ohio
Long-term mechanical circulatory support devices are currently an
established therapy for the management of end-stage heart failure and
current evidence supports their superiority compared with maximal medical
therapy in these patients. Implantation of left ventricular assist devices
(LVAD) as destination therapy in patients considered ineligible for heart
transplantation has resulted in improved survival, quality of life, and func-
tional status. Screening for peripheral arterial disease and abdominal aortic
aneurysm (AAA) before LVAD implantation is recommended. Although
repair of AAA before during LVAD placement has been reported, surveil-
lance and management strategies of AAA after LVAD implantation need to
be further investigated.We describe our surveillance program,management,
and operative strategies in two patients on destination LVAD therapy who
underwent successful endovascular AAA repair. Meticulous preoperative
workup and counseling, with special attention to bridging of anticoagula-
tion therapies and careful intraoperative monitoring, including the hemo-
dynamic management of a nonpulsatile, continuous-flow system are critical
to successful outcomes. Endovascular AAA repair is feasible in patients with
destination LVAD therapy and should be considered in those with AAA and
a reasonable life expectancy.
Third Time’s the Charm: Repair of Complex Thoracic Aneurysm in a
Patient with Relapsing Polychondritis
Peter JB Hunt, MD, Robert March, MD, Aksim Rivera, MD, Chad E.
Jacobs, MD, and Walter J. McCarthy, MD. Department of Cardiovascular
and Thoracic Surgery, Rush University Medical Center, Chicago, Ill
Objectives: This report describes the diagnosis and treatment of a
complex thoracic aneurysm in a patient with relapsing polychondritis (RP).
Methods:Review of this rare disorder, its complications, and principles
of thoracic aneurysm repair.
Results: A 29 year-old woman with a history of RP and open repair of
a proximal descending thoracic aneurysm presented with hemoptysis and
right lower lobe blastomycosis pneumonia. Chest computed tomography
showed two areas of thoracic aneurysmal dilatation—at the ascending aorta/
arch and the distal descending aorta, straddling the area of her previous open
repair (Fig 1). The patient was initially treated conservatively, but returned 3
months later with symptomatic aneurysm expansion of the ascending/arch
aneurysm. She therefore underwent ascending and aortic arch replacement
with reimplantation of the arch vessels (Fig 2). She subsequently underwent
endovascular repair of the distal descending thoracic aorta when the distal
aneurysm expanded and became symptomatic (Figs 3 and 4). RP is a rare
disease with an incidence of 3.5 per million individuals annually, 1% of
whomdevelop aneurysmal disease. Antibodies to type II collagen are present
in 50% to 60% of these, and there is an association with HLA-DR4. Areas
most commonly affected include the auricular cartilage and the tracheo-
bronchial tree. Medical management is aimed at immunosuppression via
steroids and monoclonal antibodies (ie infliximab). First described in 1923
by Jaksch-Wartenhorst, thoracic aneurysm repair in these patients has been
most recently described in 2006 by Caceres. To our knowledge this is the
youngest reported patient with RP to require thoracic aneurysm repair; the
only description of repair of both the ascending and descending aorta in a
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patient with RP; and the first reported case describing endovascular tech-
nique to treat such a patient.
Conclusions: Relapsing polychondritis is a rare cause of aortic aneu-
rysm. The disease carries a poor prognosis overall, and the success of surgical
repair has yet to be determined. The use of endovascular technique may be
an additional tool to provide expeditious and durable repair in patients with
this rare and complex disorder.
Intermittent Foot Claudication With Plantar Flexion as a Result of
Dorsalis Pedis Artery Impingement in an Irish Dancer
Brigitte Smith, MD, Travis Engelbert, MD, and William Turnipseed, MD.
Vascular Surgery, University of Wisconsin, Madison, Wisc
Case report: A 17-year-old Irish dancer developed erythema, pares-
thesias, and coolness over the forefeet, worse with dancing, over 1 year. She
had no history of Raynaud disease. She was otherwise healthy, took no
medications, and her family history was negative for collagen vascular
diseases or vasculitides. There was ruddy discoloration of the toes extending
into the forefeet. Her forefeet and toes were cold, without ulceration or
necrosis. Ankle-brachial indices were 1.16 on the right and 1.05 on the left
with normal digital waveforms.Magnetic resonance angiography (MRA) of
the pelvis and lower extremities, including imaging of the feet in both
neutral and plantar flexed positions, revealed three focal stenoses of the left
dorsalis pedis (DP) artery and one focal stenosis of the right DP artery on
plantar flexion only. All areas of stenosis resolved upon neutral positioning.
Atypical forefoot claudication with angiographic evidence of compression of
the DP artery in plantar flexion was consistent with anomalous tissue bands
secondary to dancing footwear and overuse. Surgical exposure and release of
the tissue was undertaken. Three small skin incisions were made directly over
the impingement sites documented by ultrasound imaging. Dissection was
carried down to the DP artery. Several tissue bands were noted obliquely
crossing the DP artery. With forced plantar flexion, these bands caused
severe constriction, documented by absence of signal with Doppler exami-
nation. After resection of the bands, triphasic arterial waveforms with the
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